CN Stock MarketDetailed Quotes

Chengdu Olymvax Biopharmaceuticals Inc (688319)

Watchlist
  • 24.75
  • -4.44-15.21%
Market Closed Jan 16 15:00 CST
10.04BMarket Cap156.65P/E (TTM)

Chengdu Olymvax Biopharmaceuticals Inc (688319) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
Main business305.11M99.76%
Other business736.41K0.24%

By Industry

Currency:CNY
2024/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing industry586.1M99.53%
Other business2.75M0.47%

By Country/Region

Currency:CNY
2024/FY
Stock NameRevenueRatio
East China229.3M38.94%
Central China114.62M19.46%
Southwest87.46M14.85%
North China60.44M10.26%
South China58.45M9.93%
Northwest22.32M3.79%
Northeast China13.52M2.30%
Other business2.75M0.47%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
View More
Nancy Pelosi Portfolio
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More